Bonus Episode: Dr. Alison Tree - Consultant Clinical Oncologist in the MR Linac Series

**Trigger Warning**

Naman Julka-Anderson and Jo McNamara catch up with Dr. Alison Tree’s about her career,  prostate cancer treatment and the future of MR Linac research. 
​​ 
​​To use this podcast as CPD, look at these reflection points: 
​​1. Read the associated documents and research.
2. ​​Reflect on your current practice and consider how the MOMENTUM study findings align with, or challenge your existing approaches to prostate cancer management. 
​​    
​​​​Complete this form for your accredited digital badge: https://bit.ly/3GbtR1X.
​​
​​Links from podcast:
​​The Society and College of Radiographers (SCoR) publishes this guidance document for the therapeutic radiography profession and education providers with an overview of the educational and professional requirements for the profession to support safe, effective use of magnetic resonance imaging (MRI) in radiotherapy for the purposes of simulation (MRSim) or on-board radiotherapy guidance (MR-RT): https://www.sor.org/getmedia/3be2a7d1-2d57-4d6b-b4ef-60368a3b7eae/mri_guided_radiotherapy-1.pdf_2.

Daily adaptive radiotherapy for patients with prostate cancer using a high field MR-linac: Initial clinical experiences and assessment of delivered doses compared to a C-arm linac: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210377/.

5-Year Outcomes from PACE B: An International Phase III Randomized Controlled Trial Comparing Stereotactic Body Radiotherapy (SBRT) vs. Conventionally Fractionated or Moderately Hypo Fractionated External Beam Radiotherapy for Localized Prostate Cancer:

The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505056/

​​Please like and subscribe to Rad Chat on your podcast library.
​​
​​Our links:
​​Link Tree: https://linktr.ee/radchat 

Music and jingle credits: Dr. Ben Potts and Adam Cooke.
All rights reserved